India, Sept. 30 -- Moderna, Inc. (MRNA) is down 6.68 percent, losing $13.60 to $189.86 on Wednesday. The move comes after the company announced the addition of a Chief Operating Officer role as it prepares for the potential launch and scale-up of intismeran autogene and advances its broader oncology and infectious disease portfolios.
Moderna is currently trading at $189.86, down from the previous close of $203.46 after opening at $186.55 on the Nasdaq. The stock has traded between $184.58 and $196.83 during the session, with trading volume at 8.54 million shares versus average volume of 17.03 million.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Juan Andres will return to Moderna as Chief Operating...